Pilot study of redirected autologous T cells engineered to contain anti-CD19 attached to TCRζ and 4-1BB signaling domains in patients with chemotherapy-resistant or -refractory CD19+ leukemia and lymphoma.
Stephan A. Grupp
No relevant relationships to disclose
David L. Porter
Research Funding - Novartis
Bruce Levine
Employment or Leadership Position - University of Pennsylvania
Research Funding - Novartis
Michael Kalos
Employment or Leadership Position - University of Pennsylvania
Christine Strait
No relevant relationships to disclose
Susan R. Rheingold
No relevant relationships to disclose
Richard Aplenc
No relevant relationships to disclose
Carl H. June
Honoraria - Novartis
Research Funding - Novartis